EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Enteral nutrition support in patients with cancer: association of short-term prognosis and medical costs with inflammation

Chenan Liu, Li Deng, Shiqi Lin, Tong Liu, Jiangshan Ren, Jinyu Shi, Heyang Zhang, Hailun Xie, Yue Chen, Xin Zheng, ZhaoTing Bu, Hanping Shi

Supportive Care in Cancer · 2025

DOI: 10.1007/s00520-024-09085-y ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Chenan Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Enteral Nutrition, Health Care Costs, Inflammation, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China,China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Enteral nutrition (EN) is commonly used for nutritional support in patients with cancer. Whether inflammation, one of the driving factors of malnutrition and cancer, affects the association between EN and short-term prognosis and medical costs in patients with cancer remains unclear. We aimed to investigate the association between EN and short-term prognosis of patients with cancer and the effect of inflammation on EN-associated medical costs. METHODS: This multicentre prospective cohort study evaluated patients with pathologically confirmed solid tumours. After admission, all patients who received EN, including oral or tube feeding, were assigned to the EN group. The log-rank test was used to identify the optimal cutoff values for inflammatory markers. Cox regression analysis was used to analyse the associations among EN, inflammation, and prognosis. Propensity score matching was used to balance biases between the EN and non-EN groups and validate the stability of the results. RESULTS: A total of 5121 patients were included, with 2965 (57.90%) men and an average age of 59.06 (11.30) years. A total of 462 patients received EN, with 390 (84.4%) receiving oral nutritional supplementation. During the 90-day follow-up, 304 patients died. In the low inflammation group, there was no association between EN and short-term prognosis (hazard ratio [HR] = 0.92, 95% confidence interval [CI] = 0.39-2.18). In the high inflammation group, EN significantly improved the short-term prognosis (HR = 0.48, 95% CI = 0.30-0.76). In patients with low inflammation (p < 0.001), EN increased hospitalisation costs (p < 0.001) without reducing length of stay (LOS) (p = 0.15). In patients with high inflammation, EN did not increase hospitalisation expenses (p = 0.47) but reduced the LOS (p = 0.004). CONCLUSION: EN can improve the short-term prognosis of patients with high inflammation and reduce LOS without increasing the hospitalisation expenses. Baseline inflammation levels may serve as effective indicators for personalised and precise EN treatment. CLINICAL TRIAL REGISTRATION: ChiCTR1800020329 (chictr.org.cn).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enteral NutritionHealth Care CostsInflammationNeoplasmsAgedFemaleHumansMaleMiddle AgedCohort StudiesMalnutritionPrognosisPropensity ScoreProspective Studies

Stichwörter der Autor:innen

CancerEnteral nutritionInflammationMedical costsShort-term prognosis

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
  • Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China.
  • National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Department of Oncology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.
  • Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. shihp@ccmu.edu.cn.

Förderung

  • National Key Research and Development Program of China,China

Zitieren

APA

Liu, C., Deng, L., Lin, S., Liu, T., Ren, J., Shi, J., Zhang, H., Xie, H., Chen, Y., Zheng, X., Bu, Z., & Shi, H. (2025). Enteral nutrition support in patients with cancer: association of short-term prognosis and medical costs with inflammation. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-09085-y

Vancouver

Liu C, Deng L, Lin S, Liu T, Ren J, Shi J, et al. Enteral nutrition support in patients with cancer: association of short-term prognosis and medical costs with inflammation. Supportive Care in Cancer. 2025. doi:10.1007/s00520-024-09085-y

BibTeX
@article{Liu2025,
  author = {Liu, Chenan and Deng, Li and Lin, Shiqi and Liu, Tong and Ren, Jiangshan and Shi, Jinyu and Zhang, Heyang and Xie, Hailun and Chen, Yue and Zheng, Xin and Bu, ZhaoTing and Shi, Hanping},
  title = {Enteral nutrition support in patients with cancer: association of short-term prognosis and medical costs with inflammation},
  journal = {Supportive Care in Cancer},
  year = {2025},
  doi = {10.1007/s00520-024-09085-y}
}
Kostenlos starten →